Search Results 2231-2240 of 12417 for waardenburg syndrome

1. A Study To Assess Whether Etrolizumab Is A Safe And Effective Treatment For Participants With Moderately To Severely Active Crohn's Disease (CD) - Mayo Clinic

   At Week 14 (end of Induction Phase), participants achieving decrease of 70 points in Crohn's Disease Activity Index (CDAI) from baseline (CDAI-70 response) ...

2. Study To Evaluate The Effect Of Fluticasone Furoate/Vilanterol On Survival In Subjects With Chronic Obstructive Pulmonary Disease - Mayo Clinic

   The purpose of this study is to determine if fluticasone furoate/vilanterol improves survival in patients with chronic obstructive pulmonary disease with a ...

3. Familial adenomatous polyposis - Doctors and departments - Mayo Clinic

   ... disease, Colon polyps, Lynch syndrome, Anal fistula, Polyposis syndromes, Recurrent cancer, Anorectal disease. Show more areas of focus for Eric J. Dozois ...

4. Overview - Psychiatric Genomics and Pharmacogenomics Program - Mayo Clinic Research

   Johnson Genomics of Addiction Program, the Bipolar Disorder Biobank and pharmacogenomics research studies of response to antidepressant medicine. The program ...

5. Amyotrophic lateral sclerosis (ALS) - Doctors and departments - Mayo Clinic

   This nervous system disease, also known as Lou Gehrig's disease, destroys nerve cells and gets worse over time.

6. Overview - eMERGE Genome Informed Risk Assessment - Mayo Clinic Research

   These scores estimate the overall risk of getting a disease from common variants in multiple genes. A genetic variant is a change in the DNA sequence that ...

7. Broken collarbone - Doctors and departments - Mayo Clinic

   ... syndrome, Shoulder subluxation, Dislocated shoulder, Dislocation, SLAP tear, Elbow instability, Separated shoulder, Shoulder instability, Joint instability ...

8. A Study To Evaluate Safety And Effectiveness Of SHP647 As Induction Therapy In Participants With Moderate-to- Severe Crohn's Disease - Mayo Clinic

   Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

9. High-Dimensional Phenotyping: Charles J. Bruce, Rickey E. Carter, Antonio J. Forte, Clifton R. Haider, Christopher J. McLeod

   Every clinician can see deeper into disease pathways. Every study benefits from precise, real-time digital biomarkers. In pursuit of this vision, the lab ...

10. Collaborators - Genetics of Liver Disease: Kirk J. Wangensteen - Mayo Clinic Research

    Kirk J. Wangensteen, M.D., Ph.D., engages in research collaborations with other Mayo Clinic investigators.